Bertin Bioreagent

anti-XPD (Xeroderma pigmentosum group D), mAb (2F6)

As low as CHF 778.00
In stock
Only %1 left
BRT-G01072-R100100 µlCHF 778.00
 

Specifications / Handling

More Information
Product Details
Synonyms Xeroderma Pigmentosum Group D-complementing Protein; DNA Repair Protein Complementing XP-D Cells; General Transcription and DNA Repair Factor IIH Helicase/Translocase Subunit XPD; TFIIH subunit XPD; DNA Excision Repair Protein ERCC-2
Product Type Monoclonal Antibody
Properties
Clone 2F6
Isotype Mouse IgG1κ
Source/Host Mouse
Immunogen/Antigen Synthetic peptide.
Application ELISA, Western Blot, Immunoprecipitation, Immunocytochemistry. Recommended dilutions: 1/500-1/5000.
Specificity Recognizes human and mouse TFIIHp80/XPD.
Formulation Liquid. Does not contain any preservative.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Bertin Bioreagent
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 3 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF Download PDF

Scientific Background Information

Product Description
XPD is a DNA helicase that plays a critical role in both Nucleotide Excision Repair (NER) and transcription. It is part of the TFIIH complex, where it functions alongside XPB to unwind DNA during repair and transcription initiation. XPD works as a 5? to 3? helicase, separating the DNA strands around a lesion. It functions after damage recognition (by XPC) and verification (by XPA). XPD interacts with checkpoint proteins that regulate cell cycle progression after DNA damage. It may also influence apoptosis in response to severe damage. Mutations in XPD (ERCC2) cause Xeroderma Pigmentosum (XP-D). This leads to extreme UV sensitivity, freckling, and pigmentation abnormalities.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.